interview

ASHG recently spoke with Julie Gerberding, MD, MPH, President and CEO of the Foundation for the National Institutes of Health (FNIH), on how this organization leverages expertise across a breadth of scientific industries to address complex health challenges and accelerate research, particularly in human genetics and genomics.  The FNIH is an independent, not-for-profit 501(c)(3) charitable... Read More

By: Meenakshi Ramaswamy, MD As ASHG celebrates its 75th anniversary, we must take time to reflect upon the importance of this celebration. ASHG has been essential towards the advancement of research in human genetics, thus we must not take this anniversary for granted. To help recognize the amazing events that will take place during the... Read More

Morteza Seifi, MS Meet Honey, a professional who has traversed different fields and industries throughout her career. Honey’s background is in biotechnology, and her research interests have been focused on viral etiology, cancer mechanisms, and biomarkers for the early detection of cancer. Currently, she works at the Medical College of Wisconsin. Honey’s career trajectory has... Read More

ASHG, alongside our advocacy partners, continues to help Congress see the impact of human genetics and genomics research, and that robust and sustained funding for the NIH is vital for advancing scientific progress and creating hope. The Messenger recently spoke with a patient participant (who wished to remain anonymous) enrolled in NIH’s Undiagnosed Diseases Network... Read More

The ASHG membership team recently sat down with Minna Kaikkonen-Määttä, PhD, a Professor of Cardiovascular Genomics at the University of Eastern Finland and member of the Member Engagement Committee. As an international member of ASHG’s community, she has had the opportunity to collaborate across the world and expand her research. Dr. Kaikkonen-Määttä shared her lab’s... Read More